We found that no single agent is associated with a significant improvement of survival, although a positive trend towards mortality reduction exists for all the three drugs analysed.
← all excerpts
Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials.
1
—
—